Common Peptide/GLP-1 Complications and Side Effects Even though many patients tolerate these therapies well, complications are not uncommon
Nevertheless, these findings have not been replicated in robust human clinical trials, and the relevance to Hashimoto's management remains speculative
Additionally, IL-6 infusion elevates GLP-1 in mice but not in humans, underscoring species-specific regulation of inflammation
By restoring that signaling with a medication like semaglutide, its hypothesized we can relieve pain and possibly reduce bloating
While these methods can be effective for some, many patients find that they need additional support
Surgery, by contrast, is a one-time intervention